Posted Sep. 29, 2011 at 7:44 a.m.

Premium Lock BioDelivery Sciences drug candidate fails in trial

Published: 2011-09-29 07:44:24
Updated: 2011-09-29 07:44:24

BDSI BDSI

The chronic pain reliver didn't perform better than a placebo in a Phase 3 clinical trial, but the Raleigh company isn'r giving up....

Read More
Read More

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll